论文部分内容阅读
目的探讨氯吡格雷及前列地尔治疗急性脑梗死的临床效果。方法整取抽样2016年1月至2017年1月我院急性脑梗死患者56例,按随机数字表法分为2组,对照组28例,给予常规治疗,观察组28例,在对照组基础上联合前列地尔和氯吡格雷治疗,均治疗2周后,比较两组治疗效果,并评价其用药安全性。结果观察组治疗总有效率高于对照组(P<0.05);且两组不良反应发生率比较差异无统计学意义(P>0.05)。结论对急性脑梗死患者采取前列地尔联合氯吡格雷治疗的效果较好,改善患者临床症状,且用药安全。
Objective To investigate the clinical effects of clopidogrel and alprostadil in the treatment of acute cerebral infarction. Methods From January 2016 to January 2017, 56 patients with acute cerebral infarction in our hospital were divided into two groups according to the random number table method and 28 patients in the control group. The patients in the observation group were given routine treatment and the observation group consisted of 28 patients in the control group On the combination of alprostadil and clopidogrel treatment, were treated for 2 weeks, the two groups were compared the therapeutic effect, and evaluate the safety of medication. Results The total effective rate of observation group was higher than that of control group (P <0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). Conclusions The treatment of patients with acute cerebral infarction with alprostadil and clopidogrel is effective and can improve the clinical symptoms and safety of medication.